BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 20.05.1994

Food and Drug Administration

The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on a proposal to revoke the establishment and product licenses of Central Georgia Plasma Labs, Inc., due to significant noncompliance with biologics regulations.

Source: Federal Register — Health and Human ServicesOpen original release →